Skip Navigation
Mortar_and_pestel

Regimen Information

For 5FU + cisplatin + radiation, including Side Effects

5FU + cisplatin + radiation

Drugs in this Regimen:

For the treatment of Esophageal Cancer

How 5FU + cisplatin + radiation chemotherapy is given and possible side effects.

5FU + cisplatin + radiation for the treatment of Esophageal Cancer

5FU + Cisplatin + Radiation is a chemoradiation regimen used in the treatment of esophageal cancer. This treatment involves two chemotherapy drugs: cisplatin and fluorouracil, which is also known as 5FU and also radiation therapy.

MOST COMMON SIDE EFFECTS OF 5FU + CISPLATIN + RADIATION

  • Nausea & Vomiting

  • Risk of Infection

  • Bruising and Bleeding

  • Anemia

  • Constipation

  • Numbness in Hands and Feet

  • Fatigue

For more information, see the 'Expert Resources' tab below.

Community Responses

Often, the most helpful information regarding treatment side effects comes not from clinical brochures, but rather from other patients like you. We've collected the most helpful community resources to help you prepare for the side effects and coping tips for your chemotherapy regimen.

What side effects did you experience while on this medication?

There are currently no answers to this question. Be the first to answer!

This discussion needs your voice!

What were the specific side effects that you experienced while taking this medication? How did you manage them?

What coping tips would you give to new patients on this regimen?

There are currently no answers to this question. Be the first to answer!

This discussion needs your voice!

What do you wish you had known before taking this medication? What information would you like to pass on to patients who are beginning this medication?

Treatment Overview

This chemotherapy regimen is commonly used to treat:

Other chemotherapy regimens for the treatment of Esophageal Cancer:

See Expert Resources

The Navigating Care Library includes articles about cancer, chemotherapy regimens and drugs from the the National Cancer Institute and other experts.